SCHEMBL100284

SCHEMBL100284

O=C1NC(=O)C(Cc2ccc3c(c2)c2ccccc2c(=O)n3Cc2ccccc2)S1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.50
PPARA Q07869 2/20 0.50
PPARG P37231 4/20 0.48
ALDH1A1 P00352 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SRC P12931 1/20 0.44
MAPT P10636 1/20 0.44
PTPN1 P18031 1/20 0.43
PGR P06401 2/20 0.42
AKT1 P31749 1/20 0.42
PIK3CA P42336 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA2 P00918 1/20 0.41
MAOB P27338 1/20 0.41
MAOA P21397 1/20 0.41
CISD1 Q9NZ45 1/20 0.41
RORA P35398 1/20 0.41
RORC P51449 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4778666 0.84 FFAR1 (0.48) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL4778234 0.81 KDM4E (0.53) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL5322829 0.79 FFAR1 (0.45) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL9052053 0.78 FFAR1 (0.50) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL5324367 0.76 PPARG (0.50) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL8686619 0.76 FFAR1 (0.57) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL4781441 0.75 PTPN1 (0.52) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL97465 0.74 FFAR1 (0.46) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL166570 0.74 PPARG (0.74) FFAR1PPARAPPARGALDH1A1NPSR1
SCHEMBL4780233 0.74 HDAC6 (0.43) FFAR1PPARAALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 FFAR1 505/4885PPARA 1465/4885PPARG 1682/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 FFAR1 505/4885PPARA 1465/4885PPARG 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.